ESC 365 - Risk and causes of hospital admission in patients with atrial fibrillation on treatment with oral anticoagulants

ESC Premium Access

Risk and causes of hospital admission in patients with atrial fibrillation on treatment with oral anticoagulants

Session: Risk assessment and prognosis in atrial fibrillation

Topic: Rhythm Control, Antiarrhythmic Drugs

Speaker: Doctor A. Pannunzio (Rome, IT)

Event: ESC Congress 2024

Congress Presentation

About the speaker

Doctor Arianna Pannunzio

Sapienza University of Rome, Rome (Italy)

0 follower

5 more presentations in this session

Invasive haemodynamic assessment shows the obesity-HFpEF phenotype is common amongst patients with symptomatic AF

Speaker: Doctor J. Ariyaratnam (Adelaide, AU)

The association of NT-proBNP levels in atrial fibrillation patients and 3-year risk of heart hospitalization and death

Speaker: Doctor K. Szummer (Stockholm, SE)

Ambulatory polygraphy as a screening tool for obstructive sleep apnea in combination with semi-continuous rhythm monitoring in patients with atrial fibrillation: a pilot study

Speaker: Miss R. Onder (Hasselt, BE)

An external validation of DOAC score in patients with atrial fibrillation following transcatheter aortic valve replacement

Speaker: Doctor Y. Harano (Gifu, JP)

Novel predictor of thrombosis after left atrial appendage closure -Neutrophil to Lymphocyte Ratio (NLR), platelet to LymPhocyte Ratio (PLR), and Lymphocyte to Monocyte Ratio (LMR)-.

Speaker: Doctor S. Ryuzaki (Chiba, JP)

Access the full session

Risk assessment and prognosis in atrial fibrillation

Speakers: Doctor A. Pannunzio, Doctor J. Ariyaratnam, Doctor K. Szummer, Miss R. Onder, Doctor Y. Harano...

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources